Alphathesin, a new steroid anaesthetic agent.
This is a study of 220 patients, most of them out-patients, who were anaesthetized with Alphatehsin. Although the use of Alphathesin has not been discussed in depth, one can say that it is not a substitute for other intravenous anaesthetics available at the present time. Alphathesin, however, deserves further study as it may be able to supply new solutions to new problems which are encountered daily in our specialty, particularly in the field of out-patient surgery.
D000293:Adolescent; D000328:Adult; D000530:Alfaxalone Alfadolone Mixture / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D000771:Anesthesia, Intravenous; D002648:Child; D004305:Dose-Response Relationship, Drug; D005260:Female; D006221:Halothane / Q000008:administration & dosage; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009609:Nitrous Oxide / Q000008:administration & dosage; D010044:Outpatient Clinics, Hospital; D011277:Pregnanediones; D012119:Respiration / Q000187:drug effects; D013514:Surgical Procedures, Operative; D013997:Time Factors; D014202:Tremor / Q000139:chemically induced
D011277:Pregnanediones; D000530:Alfaxalone Alfadolone Mixture; D009609:Nitrous Oxide; D006221:Halothane